Mark Deitch founded BioScience Communications in 1995 as a company dedicated to scientific quality and ethical performance. He specializes in developing the strategy, messaging, and narrative driving a wide range of health, medical, and regulatory communications programs. Mark has longstanding experience in cardiovascular medicine, immunology, and neuroscience, among many other therapeutic categories, and has worked on health economics and pharmacogenomic issues and products. He writes and speaks frequently on such topics as industry-professional relationships, the challenge of science communications, and the ethics of medical education. Mark completed his undergraduate studies at SUNY Binghamton and undertook graduate work and teaching at New York University.